Calidi Biotherapeutics, Inc. — All Filings
376 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
25
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
NT 10-Q
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | 10-K | 0001493152-26-013242 | Mar 27, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001493152-26-013236 | Mar 27, 2026 | — |
| 8-K | 8-K | 0001493152-26-009701 | Mar 11, 2026 | Mar 5, 2026 |
| SCHEDULE 13D | — | 0002109116-26-000003 | Mar 9, 2026 | — |
| 424B5 | 424B5 | 0001493152-26-009239 | Mar 9, 2026 | — |
| 424B5 | 424B5 | 0001493152-26-009027 | Mar 6, 2026 | — |
| S-3MEF | S-3MEF | 0001493152-26-009037 | Mar 5, 2026 | — |
| SCHEDULE 13G/A | — | 0001493152-26-005942 | Feb 10, 2026 | — |
| 8-K | 8-K | 0001493152-26-005840 | Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G | — | 0002109116-26-000002 | Feb 4, 2026 | — |
| 8-K | 8-K | 0001493152-26-004089 | Jan 29, 2026 | Jan 28, 2026 |
| 4 | 4 | 0001493152-25-028030 | Dec 16, 2025 | Dec 12, 2025 |
| 10-Q | 10-Q | 0001493152-25-022372 | Nov 13, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001493152-25-022349 | Nov 13, 2025 | — |
| 8-K | 8-K | 0001493152-25-021418 | Nov 10, 2025 | Nov 7, 2025 |
| 8-K | 8-K | 0001493152-25-020390 | Oct 31, 2025 | Oct 27, 2025 |
| 8-K | 8-K | 0001493152-25-019353 | Oct 24, 2025 | Oct 22, 2025 |
| 8-K | 8-K | 0001493152-25-014293 | Sep 19, 2025 | Aug 8, 2025 |
| 4 | — | 0001641172-25-026782 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | — | 0001641172-25-026780 | Sep 5, 2025 | Sep 3, 2025 |
| 4 | — | 0001641172-25-026781 | Sep 5, 2025 | Sep 3, 2025 |
| 8-K | 8-K | 0001641172-25-026066 | Aug 29, 2025 | — |
| SCHEDULE 13G | — | 0001641172-25-025645 | Aug 27, 2025 | — |
| 3 | 3 | 0001641172-25-025641 | Aug 27, 2025 | Aug 20, 2025 |
| 4 | — | 0001641172-25-025448 | Aug 25, 2025 | Aug 21, 2025 |
| 4 | — | 0001641172-25-025447 | Aug 25, 2025 | — |
| 4 | 4 | 0001641172-25-025446 | Aug 25, 2025 | Aug 21, 2025 |
| 4 | 4 | 0001641172-25-025445 | Aug 25, 2025 | Aug 21, 2025 |
| 8-K | 8-K | 0001641172-25-025273 | Aug 22, 2025 | Aug 20, 2025 |
| 424B4 | 424B4 | 0001641172-25-025041 | Aug 21, 2025 | — |
| EFFECT | — | 9999999995-25-002698 | Aug 20, 2025 | — |
| CORRESP | — | 0001641172-25-024764 | Aug 19, 2025 | — |
| CORRESP | — | 0001641172-25-024762 | Aug 19, 2025 | — |
| S-1 | S-1 | 0001641172-25-024489 | Aug 15, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003581 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001641172-25-024190 | Aug 14, 2025 | Aug 8, 2025 |
| 10-Q | 10-Q | 0001641172-25-022797 | Aug 8, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001641172-25-022791 | Aug 8, 2025 | — |
| 8-K | 8-K | 0001641172-25-022592 | Aug 7, 2025 | Aug 4, 2025 |
| EFFECT | — | 9999999995-25-002362 | Jul 25, 2025 | — |
| 8-K | 8-K | 0001641172-25-021039 | Jul 25, 2025 | Jul 24, 2025 |
| CORRESP | — | 0001641172-25-020815 | Jul 24, 2025 | — |
| UPLOAD | — | 0000000000-25-007712 | Jul 22, 2025 | — |
| S-3 | S-3 | 0001641172-25-020279 | Jul 18, 2025 | — |
| 4 | — | 0001641172-25-019802 | Jul 15, 2025 | Jul 9, 2025 |
| 4 | — | 0001641172-25-019803 | Jul 15, 2025 | Jul 9, 2025 |
| 4 | — | 0001641172-25-019801 | Jul 15, 2025 | Jul 9, 2025 |
| 4 | — | 0001641172-25-019800 | Jul 15, 2025 | Jul 9, 2025 |
| EFFECT | — | 9999999995-25-002240 | Jul 11, 2025 | — |
| 8-K | 8-K | 0001641172-25-018808 | Jul 11, 2025 | Jul 9, 2025 |